Skip to main content

New Buffalo Bioinformatics Center To Use InforMax Software

NEW YORK, March 8-The new Center for Excellence in Bioinformatics in Buffalo, New York has signed a license agreement with InforMax for software and bioinformatics applications, the company said in a statement on Tuesday.

 

The license includes the company's GenoMax bioinformatics system and its Vector NTI Suite desktop software.

 

The new 150,000 square-foot center, which was announced last December, will be outfitted for structural biology, drug design, analysis, and commercialization and is designed to attract both academic and private sector researchers. It is backed by the state of New York as well as private companies including Compaq, InforMax, Invitrogen, Amersham, Sun, and Dell.

 

Compaq has said that it will provide $40 million worth of AlphaServer systems and Tru64 UNIX software for the center.

 

Researchers across the State University of New York system, which include 64 schools, will have access to these bioinformatics tools through the Buffalo center.

 

Financial details of the license agreement with InforMax were not disclosed. InforMax has pledged $20.8 million to help underwrite the new center.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.